Tonic-Clonic Seizures Treatment Market Trends There is a growing trend towards the use of combination therapies to manage tonic-clonic seizures. Combining multiple anti-seizure medications or ...

The Key Tonic clonic Seizure Companiesin theamrket include - Emory University, Pfizer, GlaxoSmithKline, Eisai Inc., Xenon Pharmaceuticals, UCB Pharma, Johnson ...

A phase 3 study assessing the use pregabalin as adjunctive therapy for epilepsy patients 5 to 65 years of age with primary generalized tonic-clonic (PGTC) seizures did not meet its primary endpoint to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. DENVER — Primary generalized tonic-clonic seizures ...

Researchers have discovered supplementing a normal, carbohydrate-rich diet with specific ketogenic agents may significantly delay tonic-clonic seizures caused by exposure to high levels of oxygen. The ...

Sudden unexpected death in epilepsy (SUDEP) is a leading cause of premature death, affecting 1·00–1·14 per 1000 people with epilepsy annually.1 Identifying those at high risk or low risk of SUDEP is ...

FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients two years of age and older 1 ...

Credit: Shutterstock. Eprontia is approved for the treatment of partial-onset or primary generalized tonic-clonic seizures and migraine prevention. The Food and Drug Administration (FDA) has approved ...

LONDON, June 05, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in ...

-- New approval for VIMPAT® (lacosamide) CV in the U.S. as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older -- All three ...

A recent case study details the account of a 10-year-old boy who suffered seizures after over-indulging in licorice sweets. The boy was admitted to hospital in Bologna, Italy after suffering a 2 ...

ATLANTA, June 24, 2024 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that Epilepsia published findings from a comprehensive scoping review examining the efficacy of FINTEPLA ...